Prescription medicine
Sodium pyrophosphate and stannous Brand names: Technescan
Sodium pyrophosphate and stannous (Technescan) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
- In shortage
Check it at the source: the sodium pyrophosphate and stannous FDA label on DailyMed (effective December 5, 2025); every sodium pyrophosphate and stannous label on DailyMed.
Highlights of the record
FDA label of December 5, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageTechnescan PYP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for:
Skeletal imaging to demonstrate areas of altered osteogenesis in adults
Cardiac imaging as an adjunct in the diagnosis of acute myocardial infarction in adults (See WARNINGS ) Technescan PYP, in conjunction with sodium pertechnetate Tc 99m injection for red blood cell (RBC) labeling, is indicated for gated cardiac blood pool i
Forms and strengths
- 11.9 mg/10ml / 3.2 mg/10ml
Injection (powder) (lyophilized) for solution.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- 1 of 1 presentation limited or unavailable updated October 1, 2026
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 33 through July 30, 2026
What is sodium pyrophosphate and stannous used for?
From the label: indications and usageTechnescan PYP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for:
Skeletal imaging to demonstrate areas of altered osteogenesis in adults
Cardiac imaging as an adjunct in the diagnosis of acute myocardial infarction in adults (See WARNINGS ) Technescan PYP, in conjunction with sodium pertechnetate Tc 99m injection for red blood cell (RBC) labeling, is indicated for gated cardiac blood pool imaging and for the detection of gastrointestinal bleeding sites in adults.
Source: FDA drug label (Technescan PYP), Curium US LLC, effective December 5, 2025 (SPL set 304b63f4-a32e-4700-805d-5bc9f27e7d6a), via openFDA; the full label on DailyMed
Is there a generic for sodium pyrophosphate and stannous (Technescan)?
No generic sodium pyrophosphate and stannous is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Is sodium pyrophosphate and stannous in shortage?
The FDA Drug Shortage Database lists 1 of 1 sodium pyrophosphate and stannous presentations as limited or unavailable (updated October 1, 2026); the first entry was posted on December 27, 2023.
| Presentation | Company | Status | Updated |
|---|---|---|---|
| Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20) | Curium US LLC | Current | October 1, 2026 |
Every sodium pyrophosphate and stannous presentation in the FDA shortage database
Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026
What does the sodium pyrophosphate and stannous label say about other medicines?
The sodium pyrophosphate and stannous label names 3 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Betiatide | warnings | Avoid heparinized catheter systems for administration of Technescan PYP. |
| Heparin | warnings | Gated cardiac blood pool and gastrointestinal bleed imaging may be impaired in patients receiving sodium heparin for anticoagulant therapy. |
| Technetium tc 99m pyrophosphate | drug interactions | Drug Interactions The biodistribution of technetium Tc 99m pyrophosphate may be altered in the presence of high levels of certain cations (iron, calcium, and aluminum). |
Check sodium pyrophosphate and stannous against other medicines
Source: FDA drug label (Technescan PYP), Curium US LLC, effective December 5, 2025 (SPL set 304b63f4-a32e-4700-805d-5bc9f27e7d6a), via openFDA; the full label on DailyMed
What do FAERS reports show for sodium pyrophosphate and stannous?
The FDA Adverse Event Reporting System holds 33 reports that list sodium pyrophosphate and stannous among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 9 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Sodium pyrophosphate and stannous side effects
- the label's list beside FAERS reports
- Sodium pyrophosphate and stannous shortage record
- every presentation, company and date
- Check an interaction
- what two or more labels say about each other